Pasar al contenido principal

ESTUDIO DE COMO LAS INTERACCIONES BACTERIANAS Y LAS CONDICIONES MICROAMBIENTALES INFLUYEN EN LA DINAMICA DE LA INFECCION

PID2024-158933OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para la Investigación y el Desarrollo Experimental
Subprograma Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intravesical mycobacteria reshape bladder and gut microbiota in a murine bladder cancer model

  • Campo-Pérez, Víctor
  • Guallar-Garrido, Sandra
  • Cabrera-Rubio, Raúl
  • Herrero-Abadía, Paula
  • Seguí-Moll, Arnau
  • Torres-Puente, Manuela
  • Cano-Jiménez, Pablo
  • Comas, Iñaki
  • Torrents, Eduard
  • Julián, Esther
13 páginas, 8 figuras, The bladder microbiota may influence tumor progression and responses to intravesical therapies, yet the effects of Mycobacterium bovis BCG instillations on bladder and gut microbiota remain unexplored. This study evaluates, for the first time, the impact of M. bovis BCG and Mycobacterium brumae, a non-pathogenic immunomodulator, on microbiota composition in bladder tissue and cecal stool of healthy and tumor-bearing mice. Mycobacterial instillations increased gut microbial richness but reduced Actinobacteria. In tumor-bearing mice, Muribaculaceae and Bacteroidaceae were enriched, while M. bovis BCG reduced Muribaculaceae and increased Rikenellaceae. In the bladder, M. brumae instillations favored Staphylococcaceae in healthy mice, while Enterococcaceae dominated most groups except M. bovis BCG-treated tumor-bearing mice. Escherichia/Shigella decreased in mycobacteria-treated tumor-bearing mice, while Burkholderia was more prevalent in untreated bladders. Notably, M. brumae increased stool alpha diversity, whereas M. bovis BCG reduced bladder richness. These findings reveal that intravesical mycobacterial therapy modulates microbiota composition across body sites, underscoring the complex host-tumor-immunotherapy interplay., R.C.-R. thanks Generalitat-Valenciana (GVA) for the grant Plan GenT-Talent Attraction program (CDEIGENT 2020). V.C.-P. and A.S.-M. acknowledge AGAUR (Generalitat de Catalunya) for their support through the FI fellowship (2019 FI_B 00320 and 2022 FI_B 00822) during the period in which this work was carried out. This research was funded by grants PID2021-122331OB-I00, PID2021-125801OB-100, PID2024-158933OB-I00, PLEC2022-009356, PID2022-137607OB-I00, and PDC2022-133577-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE, MycoNET (RED2018-102677-T and RED-153634-T) and the CERCA program and AGAUR-Generalitat de Catalunya (2021SGR-01545 and 2021SGR-0092). RCR thanks Generalitat-Valenciana for the grant Plan GenT project (CDEIGENT 2020-02) and the Spanish government MCIN/AEI to the IATA-CSIC as Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). E.T. is a researcher of the ICREA Academia 2025 program. E.J. is a Serra-Húnter fellow.